Fondazione IRCCS Policlinico San Matteo — Pavia, Lombardy

Public research footprint of Fondazione IRCCS Policlinico San Matteo, compiled from the ClinicalTrials.gov public registry.

571

Registered studies

278

Active

178

Recruiting now

193

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Accelerated Phase Chronic Myeloid Leukemia · Diffuse Large B-cell Lymphoma (DLBCL) · Leukemia, Myeloid, Acute

Recently updated registry entries

NCT07204275 — Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With… (Recruiting)
NCT04728893 — Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic… (Recruiting)
NCT03394365 — A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Fondazione IRCCS Policlinico San Matteo?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.